Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

SHINTAMET INJECTION 150 mg/ml - HSA Drug Approval Details

Approvals/HSA/SHINTAMET INJECTION 150 mg/ml

Approved

THERAPEUTIC

SHINTAMET INJECTION 150 mg/ml

YUNG SHIN PHARMACEUTICAL IND CO LTD (TAIWAN)🇸🇬 Health Sciences Authority

Approval Date: Oct 31, 1994
Approval ID: b3b6ea634fbe37fc
Company: YUNG SHIN PHARMACEUTICAL IND CO LTD (TAIWAN)
Type: Therapeutic

Approval Details

Approval Id: b3b6ea634fbe37fc
Drug Name: SHINTAMET INJECTION 150 mg/ml
Product Name: SHINTAMET INJECTION 150 mg/ml
Approval Number: SIN07894P
Approval Date: 1994-10-31
Registrant: YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD
Drug Type: Therapeutic
Forensic Classification: Prescription Only
Dosage Form: INJECTION
Route Of Administration: INTRAVENOUS, INTRAMUSCULAR
Atc Code: A02BA01
Atc Item Name: cimetidine
Pharma Manufacturer Name: YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD

Active Ingredients

CIMETIDINE

150 mg/ml

CIMETIDINE

150 mg/ml

Approved

Quick Info

Agency

HSA

Country

🇸🇬

Approval Date

Oct 31, 1994

Approval ID

b3b6ea634fbe37fc

Type

Therapeutic

Back to HSA Approvals